The usual cause for the fund is to invest in rounds with 7 partakers. The meaningful sponsors for the fund in investment in the same round are SunStates Fund, MPM Capital, Long March Investment Fund. In the next rounds fund is usually obtained by UTC Investment Co., UBS Oncology Impact Fund, Surveyor Capital.
Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. Among the most popular fund investment industries, there are Medical, Biotechnology. Among the various public portfolio startups of the fund, we may underline Oncorus
The usual things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2016. The fund is constantly included in less than 2 investment rounds annually.
| Fund Name | Location |
| Atwater Capital | California, Los Angeles, United States |
| Colliers Proptech Accelerator Powered by Techstars | Canada, Ontario, Toronto |
| CSI Starlight Company | - |
| FAC Equities | Boston, Massachusetts, United States |
| Founders Future | France, Ile-de-France, Paris |
| Fred & Farid Digital Investment Fund | New York, New York, United States |
| Goodman & Company, Investment Counsel | Canada, Ontario, Toronto |
| GTR Ventures | Central, Central Region, Singapore |
| KKR Real Estate Finance Trust | New York, New York, United States |
| La Gajjar Group | Ahmedabad, Gujarat, India |
| MedScience Ventures | - |
| SHE AG | - |
| SinoVest Capital | - |
| Stanford Management | Maine, Portland, United States |
| Swallow Point Ventures | Pennsylvania, Pittsburgh, United States |
| Thin Line Capital | California, Pasadena, United States |
| Torch Electron | China, Fujian, Quanzhou |
| Valeo | Créteil, France, Ile-de-France |
| Verance Capital | - |
| Wandai Capital | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Oncorus | $57M | 19 Jul 2016 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Oncorus | $57M | 19 Jul 2016 | Cambridge, Massachusetts, United States |
